| Artificial Intelligence in radiotherapy: state of the art and future directions G Francolini, I Desideri, G Stocchi, V Salvestrini, LP Ciccone, P Garlatti, ... Medical Oncology 37, 1-9, 2020 | 69 | 2020 |
| Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility I Desideri, G Francolini, LP Ciccone, G Stocchi, V Salvestrini, M Aquilano, ... Supportive Care in Cancer 29, 2931-2937, 2021 | 23 | 2021 |
| Impact of COVID-19 on workload burden of a complex radiotherapy facility G Francolini, I Desideri, G Stocchi, LP Ciccone, V Salvestrini, P Garlatti, ... La radiologia medica 126, 717-721, 2021 | 21 | 2021 |
| Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature G Francolini, B Detti, C Becherini, S Caini, G Ingrosso, V Di Cataldo, ... Critical Reviews in Oncology/Hematology 165, 103432, 2021 | 13 | 2021 |
| Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria P Bonomo, G Stocchi, S Caini, I Desideri, V Santarlasci, C Becherini, ... European Archives of Oto-Rhino-Laryngology, 1-15, 2022 | 12 | 2022 |
| Stereotactic re-irradiation in recurrent prostate cancer after previous postoperative or definitive radiotherapy: long-term results after a median follow-up of 4 years G Francolini, M Loi, V Di Cataldo, B Detti, G Stocchi, L Masi, R Doro, ... Clinical Oncology 34 (1), 50-56, 2022 | 12 | 2022 |
| Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) G Francolini, B Detti, V Di Cataldo, P Garlatti, M Aquilano, A Allegra, ... La radiologia medica 127 (8), 912-918, 2022 | 10 | 2022 |
| Thermal Ablation versus SBRT in liver tumours: pros and cons M Loi, I Desideri, L Dominici, G Francolini, P Garlatti, LP Ciccone, ... Medical Oncology 37, 1-8, 2020 | 10 | 2020 |
| Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group L Marano, F Marmorino, I Desideri, L Carbone, A Rizzo, V Salvestrini, ... Frontiers in Nutrition 10, 1045022, 2023 | 9 | 2023 |
| Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting G Francolini, G Stocchi, B Detti, V Di Cataldo, A Bruni, L Triggiani, ... La radiologia medica, 1-8, 2022 | 9 | 2022 |
| Stereotactic body radiotherapy in oligomestatic/oligoprogressive sarcoma: safety and effectiveness beyond intrinsic radiosensitivity D Greto, M Loi, G Stocchi, V Salvestrini, F Muratori, G Scoccianti, ... The Cancer Journal 27 (6), 423-427, 2021 | 7 | 2021 |
| ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with … G Francolini, P Garlatti, M Loi, B Detti, M Aquilano, A Allegra, B Guerrieri, ... Journal of Clinical Oncology 39 (6_suppl), 118-118, 2021 | 7 | 2021 |
| Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial P Bonomo, I Desideri, M Mangoni, C Saieva, M Loi, C Becherini, C Cerbai, ... Radiotherapy and Oncology 169, 64-70, 2022 | 6 | 2022 |
| Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with … M Bernini, I Meattini, C Saieva, C Becherini, V Salvestrini, L Visani, ... Breast Cancer, 1-12, 2022 | 5 | 2022 |
| Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial … G Francolini, M Loi, V Salvestrini, M Mangoni, B Detti, V Di Cataldo, ... Clinical & Experimental Metastasis 38 (5), 451-458, 2021 | 5 | 2021 |
| Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer M Loi, G Salvatore, M Sottili, L Calosi, I Desideri, C Becherini, ... Clinical and Translational Oncology 24 (7), 1395-1402, 2022 | 3 | 2022 |
| Radiotherapy in prostate cancer after kidney transplant in 6 cases B Detti, G Stocchi, M Mariotti, A Sardaro, G Francolini, AG Allegra, ... Tumori Journal 108 (4), 371-375, 2022 | 2 | 2022 |
| Radiotherapy is effective in the management of rare penile metastases: Two case reports B Detti, A Sardaro, V Maragna, M Mariotti, G Stocchi, M Roghi, MA Teriaca, ... Cancer/Radiothérapie 25 (5), 480-483, 2021 | 2 | 2021 |
| Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I … G Francolini, P Garlatti, B Detti, A Bruni, G Mantini, S Pergolizzi, ... European Urology Open Science 21, S150, 2020 | 2 | 2020 |
| Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases I Desideri, C Becherini, L Visani, G Stocchi, E Scoccimarro, M Mariotti, ... Journal of Geriatric Oncology 11 (7), 1103-1107, 2020 | 2 | 2020 |
